SPECLIPSE
Speclipse is a transformative, patented technology for real-time, non-invasive, in-vivo cancer diagnosis utilizing laser spectroscopy and machining learning algorithms.
SPECLIPSE
Social Links:
Industry:
Biotechnology Health Care Health Diagnostics
Founded:
2015-11-01
Address:
Seongnam, Kyonggi-do, South Korea
Country:
South Korea
Website Url:
http://www.speclipse.com
Status:
Active
Contact:
82-31-698-2269
Email Addresses:
[email protected]
Total Funding:
7.7 M USD
Technology used in webpage:
Viewport Meta IPhone / Mobile Compatible SSL By Default LetsEncrypt Apple Mobile Web Clips Icon Content Delivery Network Euro Google Apps For Business Google GStatic Google Static Content
Similar Organizations
Amwise Diagnostic
Amwise Diagnostic is a leader in precision medicine technology for cancer.
Lia
Lia Diagnostics develops flush-able and eco-friendly pregnancy test.
MediQuo
Spain’s 24-hour, 7-day-a-week medical chat application.
Stel Life
Stel Life is a medical device for health care.
Healthily
Healthily is the world’s first medically approved self-care app designed around you.
Current Employees Featured
Founder
Investors List
Shinhan Capital
Shinhan Capital investment in Venture Round - Speclipse
Signite Partners
Signite Partners investment in Venture Round - Speclipse
MiCoBioMed
MiCoBioMed investment in Venture Round - Speclipse
BNH
BNH investment in Venture Round - Speclipse
MiCo
MiCo investment in Venture Round - Speclipse
Official Site Inspections
http://www.speclipse.com
- Host name: 147.62.236.23.bc.googleusercontent.com
- IP address: 23.236.62.147
- Location: Mountain View United States
- Latitude: 37.4043
- Longitude: -122.0748
- Metro Code: 807
- Timezone: America/Los_Angeles
- Postal: 94043
